MeVis Medical Solutions AG (ETR:M3V)

Market Cap	43.32M -4.0%
Revenue (ttm)	15.48M -6.9%
Net Income	1.38M -67.8%
EPS	0.76 -67.8%
Shares Out	1.82M
PE Ratio	31.29
Forward PE	n/a
Dividend	1.13 (4.71%)
Ex-Dividend Date	Mar 20, 2026

Volume	1
Open	24.00
Previous Close	23.80
Day's Range	23.80 - 24.00
52-Week Range	22.20 - 26.80
Beta	-0.04
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 27, 2026

About ETR:M3V

MeVis Medical Solutions AG develops software for recording, analyzing, and evaluating image data to manufacturers of medical devices, providers of medical IT platforms, and clinical end customers in the United States and Europe. The company provides image-based early detection and diagnosis of epidemiologically important diseases, such as breast, lung, liver, and neurological diseases. It also offers X-ray based radiography procedures, including computed tomography, mammography/digital tomosynthesis, magnetic resonance imaging, and digital sono...

• Industry: Health Information Services
• Sector: Healthcare
• Founded: 1997
• Employees: 127
• Stock Exchange: Deutsche Börse Xetra
• Ticker Symbol: M3V

Financial Performance

In fiscal year 2025, ETR:M3V's revenue was 16.06 million, a decrease of -5.36% compared to the previous year's 16.97 million. Earnings were 3.17 million, a decrease of -30.58%.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Aug 26, 2026

Data Sources Report a data error